What are the clinical manifestations of progesterone hypersensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Manifestations of Progesterone Hypersensitivity

Progesterone hypersensitivity (PH) presents with a spectrum of symptoms ranging from cutaneous eruptions to systemic anaphylaxis, typically occurring cyclically in correlation with progesterone levels during the menstrual cycle or after exposure to exogenous progesterone. 1, 2, 3

Cutaneous Manifestations

  • Urticaria and angioedema: Most common presentation, typically occurring during the luteal phase of the menstrual cycle 1, 4
  • Dermatitis/eczematous eruptions: Can appear on extremities, trunk, and face 5
  • Erythema multiforme: Characterized by target-like lesions 3
  • Fixed drug eruptions: Recurrent lesions at the same sites 3
  • Pemphigoid-like eruptions: Rare presentation with blistering 5

Systemic Manifestations

  • Respiratory symptoms: Bronchospasm, asthma-like symptoms, and throat tightness 4
  • Gastrointestinal symptoms: Nausea, vomiting, and abdominal pain 3
  • Cardiovascular symptoms: Hypotension and tachycardia in severe cases 4
  • Anaphylaxis: Life-threatening systemic reaction in severe cases 4

Timing and Pattern of Symptoms

  • Cyclical pattern: Symptoms typically begin a few days before menstruation and resolve after the menstrual period 1
  • Persistent symptoms: Some patients may experience continuous symptoms, especially with exogenous progesterone exposure 3
  • Exacerbation during pregnancy: Due to increased endogenous progesterone levels 4

Triggers

  • Endogenous progesterone: Natural hormone surges during the luteal phase of the menstrual cycle 2, 3
  • Exogenous progesterone exposure: From oral contraceptives, fertility treatments, or hormone replacement therapy 1, 2
  • Cross-reactivity: Some patients may react to multiple progestogens 3

Risk Factors

  • Previous exposure to exogenous progesterone: May sensitize individuals 1
  • Reproductive age: Most commonly affects women of childbearing age 4
  • History of atopy: May increase susceptibility to progesterone hypersensitivity 3

Diagnostic Considerations

  • Timing correlation: Symptoms that worsen during the luteal phase of the menstrual cycle or after progesterone administration 1
  • Partial response to antihistamines: Unlike typical allergic reactions, PH may only partially respond to standard antihistamine therapy 1
  • Improvement with hormonal suppression: Symptoms typically improve with medications that suppress ovulation 1, 4

Pitfalls in Diagnosis

  • Delayed diagnosis: Due to the rarity of the condition and variable presentation, diagnosis is often delayed 1
  • Misdiagnosis: Often confused with chronic urticaria, angioedema, or other dermatological conditions 3
  • Limited awareness: General lack of knowledge about PH among healthcare providers 3
  • Testing limitations: Lack of standardized commercial tests for progesterone-specific IgE 3

PH should be considered in the differential diagnosis for any woman of reproductive age presenting with cyclic hypersensitivity reactions, particularly when symptoms correlate with the luteal phase of the menstrual cycle or after exposure to exogenous progesterone. Early recognition can lead to appropriate management and improved quality of life for affected patients.

References

Research

Progestogen Hypersensitivity: Heterogeneous Manifestations with a Common Trigger.

The journal of allergy and clinical immunology. In practice, 2017

Research

A focused report on progestogen hypersensitivity.

Expert review of clinical immunology, 2023

Research

Progestogen Sensitization: a Unique Female Presentation of Anaphylaxis.

Current allergy and asthma reports, 2020

Research

A case of hypersensitivity to progesterone presenting as an eczematous eruption.

European annals of allergy and clinical immunology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.